Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200220181> ?p ?o ?g. }
- W4200220181 abstract "Abstract Current therapies for Fabry disease are based on reversing intra-cellular accumulation of globotriaosylceramide (Gb3) by enzyme replacement therapy (ERT) or chaperone-mediated stabilization of the defective enzyme, thereby alleviating lysosome dysfunction. However, their effect in the reversal of endorgan damage, like kidney injury and chronic kidney disease remains unclear. First, ultrastructural analysis of serial human kidney biopsies showed that longterm use of ERT reduced Gb3 accumulation in podocytes but did not reverse podocyte injury. Then, a CRISPR/CAS9-mediated α -Galactosidase knockout podocyte cell line confirmed ERT-mediated reversal of Gb3 accumulation without resolution of lysosomal dysfunction. Transcriptome-based connectivity mapping and SILAC-based quantitative proteomics identified alpha-synuclein (SNCA) accumulation as a key event mediating podocyte injury. Genetic and pharmacological inhibition of SNCA improved lysosomal structure and function in Fabry podocytes, exceeding the benefits of ERT. Together, this work reconceptualizes Fabry-associated cell injury beyond Gb3 accumulation, and introduces SNCA modulation as a potential intervention, especially for patients with Fabry nephropathy." @default.
- W4200220181 created "2021-12-31" @default.
- W4200220181 creator A5000783448 @default.
- W4200220181 creator A5001829252 @default.
- W4200220181 creator A5002591010 @default.
- W4200220181 creator A5004648123 @default.
- W4200220181 creator A5006650621 @default.
- W4200220181 creator A5007623557 @default.
- W4200220181 creator A5023325095 @default.
- W4200220181 creator A5026954074 @default.
- W4200220181 creator A5044946054 @default.
- W4200220181 creator A5045615753 @default.
- W4200220181 creator A5053495081 @default.
- W4200220181 creator A5054028455 @default.
- W4200220181 creator A5057371099 @default.
- W4200220181 creator A5057863019 @default.
- W4200220181 creator A5063430008 @default.
- W4200220181 creator A5068133416 @default.
- W4200220181 creator A5069514717 @default.
- W4200220181 creator A5075618597 @default.
- W4200220181 creator A5077517489 @default.
- W4200220181 creator A5082205989 @default.
- W4200220181 creator A5085653275 @default.
- W4200220181 creator A5085736815 @default.
- W4200220181 creator A5087405574 @default.
- W4200220181 date "2021-12-18" @default.
- W4200220181 modified "2023-09-27" @default.
- W4200220181 title "Synuclein alpha accumulation mediates podocyte injury in Fabry nephropathy" @default.
- W4200220181 cites W1974723464 @default.
- W4200220181 cites W1977709885 @default.
- W4200220181 cites W2015981234 @default.
- W4200220181 cites W2022356406 @default.
- W4200220181 cites W2026175550 @default.
- W4200220181 cites W2045435533 @default.
- W4200220181 cites W2051719011 @default.
- W4200220181 cites W2055136539 @default.
- W4200220181 cites W2076388898 @default.
- W4200220181 cites W2084910880 @default.
- W4200220181 cites W2089095199 @default.
- W4200220181 cites W2091164561 @default.
- W4200220181 cites W2091728196 @default.
- W4200220181 cites W2092976540 @default.
- W4200220181 cites W2113915213 @default.
- W4200220181 cites W2124364796 @default.
- W4200220181 cites W2128801503 @default.
- W4200220181 cites W2129500342 @default.
- W4200220181 cites W2133444266 @default.
- W4200220181 cites W2134451042 @default.
- W4200220181 cites W2165008949 @default.
- W4200220181 cites W2168432448 @default.
- W4200220181 cites W2168450345 @default.
- W4200220181 cites W2313827278 @default.
- W4200220181 cites W2337055769 @default.
- W4200220181 cites W2408805966 @default.
- W4200220181 cites W2474991972 @default.
- W4200220181 cites W2500404244 @default.
- W4200220181 cites W2603640757 @default.
- W4200220181 cites W2739703676 @default.
- W4200220181 cites W2749386788 @default.
- W4200220181 cites W2753292637 @default.
- W4200220181 cites W2767690268 @default.
- W4200220181 cites W2803593737 @default.
- W4200220181 cites W2840711314 @default.
- W4200220181 cites W2883331842 @default.
- W4200220181 cites W2901376861 @default.
- W4200220181 cites W2912617821 @default.
- W4200220181 cites W2974173728 @default.
- W4200220181 cites W2982155960 @default.
- W4200220181 cites W3010418309 @default.
- W4200220181 cites W4211122976 @default.
- W4200220181 doi "https://doi.org/10.1101/2021.12.17.473164" @default.
- W4200220181 hasPublicationYear "2021" @default.
- W4200220181 type Work @default.
- W4200220181 citedByCount "0" @default.
- W4200220181 crossrefType "posted-content" @default.
- W4200220181 hasAuthorship W4200220181A5000783448 @default.
- W4200220181 hasAuthorship W4200220181A5001829252 @default.
- W4200220181 hasAuthorship W4200220181A5002591010 @default.
- W4200220181 hasAuthorship W4200220181A5004648123 @default.
- W4200220181 hasAuthorship W4200220181A5006650621 @default.
- W4200220181 hasAuthorship W4200220181A5007623557 @default.
- W4200220181 hasAuthorship W4200220181A5023325095 @default.
- W4200220181 hasAuthorship W4200220181A5026954074 @default.
- W4200220181 hasAuthorship W4200220181A5044946054 @default.
- W4200220181 hasAuthorship W4200220181A5045615753 @default.
- W4200220181 hasAuthorship W4200220181A5053495081 @default.
- W4200220181 hasAuthorship W4200220181A5054028455 @default.
- W4200220181 hasAuthorship W4200220181A5057371099 @default.
- W4200220181 hasAuthorship W4200220181A5057863019 @default.
- W4200220181 hasAuthorship W4200220181A5063430008 @default.
- W4200220181 hasAuthorship W4200220181A5068133416 @default.
- W4200220181 hasAuthorship W4200220181A5069514717 @default.
- W4200220181 hasAuthorship W4200220181A5075618597 @default.
- W4200220181 hasAuthorship W4200220181A5077517489 @default.
- W4200220181 hasAuthorship W4200220181A5082205989 @default.
- W4200220181 hasAuthorship W4200220181A5085653275 @default.
- W4200220181 hasAuthorship W4200220181A5085736815 @default.
- W4200220181 hasAuthorship W4200220181A5087405574 @default.
- W4200220181 hasBestOaLocation W42002201811 @default.
- W4200220181 hasConcept C126322002 @default.